Search Results for: Cox

October 3, 2024October 3, 2024

Long-term intermittent oral administration of selective COX-2 inhibitor improved the clinical outcomes of COVID-19 in patients with cirrhosis.

Publication date: Sep 30, 2024 Patients with cirrhosis are more susceptible to coronavirus disease 2019 (COVID-19) due to immune dysfunction. In this retrospective study we aimed to investigate whether suppression ... Read more

October 3, 2024October 3, 2024

Long-term intermittent oral administration of selective COX-2 inhibitor improved the clinical outcomes of COVID-19 in patients with cirrhosis.

Coronavirus Literature

October 3, 2024October 3, 2024

Long-term intermittent oral administration of selective COX-2 inhibitor improved the clinical outcomes of COVID-19 in patients with cirrhosis.

Coronavirus Literature

October 3, 2024October 3, 2024

Long-term intermittent oral administration of selective COX-2 inhibitor improved the clinical outcomes of COVID-19 in patients with cirrhosis.

Coronavirus Literature

October 2, 2024October 2, 2024

Efficacy of inflammation-based stratification for add-on celecoxib or minocycline in major depressive disorder: Protocol of the INSTA-MD double-blind placebo-controlled randomised clinical trial.

Major Depressive Disorder Literature

Publication date: Nov 01, 2024 Different lines of evidence confirm the involvement of the immune system in the pathophysiology of major depressive disorder. Up to 30% of depressed patients present ... Read more

September 24, 2024September 24, 2024

The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study.

Coronavirus Literature

Publication date: Sep 23, 2024 The relation between use of nonsteroidal anti-inflammatory drugs (NSAIDs) and severity of COVID-19 has been the subject to debate since the outbreak of the pandemic. ... Read more

September 24, 2024September 24, 2024

The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study.

Coronavirus Literature

September 1, 2024September 1, 2024

Treatment of malignant melanoma with coxsackievirus A21 (V937): An emerging oncolytic virotherapy.

Melanoma Literature

Publication date: Sep 01, 2024 Despite rising melanoma incidence in recent decades, there is a trend towards overall decreased mortality, reflecting multiple factors including improved treatment options for metastatic disease. ... Read more

October 12, 2024October 12, 2024

Role of interleukin-6, serum ferritin, and d-dimer in hospitalized COVID-19 patients.

Coronavirus Literature

Publication date: Oct 08, 2024 Various studies have observed an association between interleukin-6 (IL-6), serum ferritin, d-dimer, and in-hospital mortality in COVID-19 patients. However, multivariate regression analysis was not done ... Read more

October 12, 2024October 12, 2024

Role of interleukin-6, serum ferritin, and d-dimer in hospitalized COVID-19 patients.

Coronavirus Literature